| Stage | SEB | % of rev | ANDE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.9B | 100.00% | $3.1B | 100.00% | ANDE ×1.06 |
| Gross profit | $221M | 7.56% | $224M | 7.22% | SEB +0.3pp |
| Operating income | $100M | 3.42% | $50M | 1.61% | SEB +1.8pp |
| Pre-tax income | $206M | 7.05% | $67M | 2.17% | SEB +4.9pp |
| Net income | $154M | 5.27% | $54M | 1.74% | SEB +3.5pp |
| Stage | SEB | ANDE | Gap · A − B |
|---|---|---|---|
| Revenue | $2.9B100.00% | $3.1B100.00% | ANDE ×1.06 |
| Gross profit | 7.56%$221M | 7.22%$224M | SEB +0.3pp |
| Operating income | 3.42%$100M | 1.61%$50M | SEB +1.8pp |
| Pre-tax income | 7.05%$206M | 2.17%$67M | SEB +4.9pp |
| Net income |
| 5.27%$154M |
| 1.74%$54M |
| SEB +3.5pp |
No disclosed counterparties: ANDE.
None